References
- Grossman A., Gaillard R. C., Cartney P. Mc., Rees L. H., Besser G. M. Opiate modulation of the pituitary-adrenal axis: effects of stress and circadian rhythm. Clin. Endocrinol. 1982; 17: 279–86
- Taylor T., Dluhy R. G., Williams G. H. β-endorphin suppresses adrenocorticotropin and cortisol levels in normal human subjects. J. Clin. Endocrinol. Metab. 1983; 57: 592–6
- Volavka J., Cho D., Mallya A., Bauman J. Naloxone increases ACTH and cortisol levels in man. N. Engl. J. Med. 1979; 30: 1056–7
- Delitala G., Devilla L., Musso N. R. On the role of dopamine receptors in the naloxone-induced hormonal changes in man. J. Clin. Endocrinol. Metab. 1983; 56: 181–4
- Facchinetti F., Petraglia F., Genazzani A. R. Localization and expression of the three opioid systems. Sent. Reprod. Endocrinol. 1987; 5: 103–13
- Loughin T., Cutler G. B., Jr. Pro-opiomelanocortin and regulation of adrenal androgens. Sem. Reprod. Endocrinol. 1987; 5: 153–9
- Jacobs H. S. Polycystic ovaries and polycystic ovary syndrome. Gynecol. Endocrinol. 1987; 1: 113–31
- Aleem F. A., McIntosh T. Elevated plasma levels of β-endorphin in a group of women with polycystic ovary disease. Fertil. Steril. 1984; 42: 686–9
- Wortsman J., Wehrenberg W. B., Gavin J. R., Allen J. P. Elevated levels of plasma β-endorphin and 3-melanocyte stimulating hormone in the polycystic ovary syndrome. Obstet. Gynecol. 1984; 63: 630–4
- Givens J. R., Wiedermann E., Andersen R. N., Kitachi A. E. β-endorphin and β-lipotropin plasma levels in hirsute women: correlation with body weight. J. Clin. Endocrinol. Metab. 1980; 50: 975–6
- Genazzani A. R., Pintor C., Facchinetti F., Carboni G., Pelosi U., Corda R. Adrenal and gonadal steroids in girls during sexual maturation. Clin. Endocrinol. 1978; 8: 15–25
- Petraglia F., Porro C., Facchinetti F., Cicoli C., Bertellini E., Volpe A., Barbieri G. C., Genazzani A. R. Opioid control of LH secretion in humans: menstrual cycle, menopause and ageing reduce effect of naloxone, but not of morphine. Life Sci. 1986; 38: 2103–10
- Facchinetti F., Grasso A., Petraglia F., Parrini D., Volpe A., Genazzani A. R. Impaired circadian rhythmicity of β-lipotropin, β-endorphin and ACTH in heroin addicts. Acta Endocrinol. 1984; 105: 149–55
- Lymangrover J. R., Dokas L. A., Kong A., Martin R., Saffran M. Naloxone has a direct effect on the adrenal cortex. Endocrinology 1981; 109: 1132–7
- Ayers J. W. T. Differential response to adrenocorticotropin hormone stimulation in polycystic ovarian disease with high and low dehydroepiandrosterone sulphate levels. Fertil. Steril. 1982; 37: 645–9
- Barnes R. B., Lobo R. O. Endogenous opioids in polycystic ovary syndrome. Sem. Reprod. Endocrinol. 1987; 5: 185–9
- Baird A., Kan K. W., Solomon S. Role of pro-opiomelano-cortin-derived peptides in the regulation of steroid production by human fetal adrenal cells in culture. J. Endocrinol. 1983; 97: 357–67
- Genazzani A. R., Facchinetti F., Pintor C., Puggioni R., Parrini D., Petraglia F., Bagnoli F., Corda R. Proopiomelanocortin related peptide plasma levels throughout prepuberty and puberty. J. Clin. Endocrinol. Metab. 1983; 57: 56–61
- Yen S. S. C., Jaffe R. B. Reproductive Endocrinology. W. B. Saunders Company, Philadelphia 1986; 241